Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching. [PDF]
Liu C +15 more
europepmc +1 more source
Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway. [PDF]
Hu AM, Chen M, Zhu CC, Zhu ZM, Xu XH.
europepmc +1 more source
Screening the Pandemic Response Box identifies novel ligands of the Staphylococcus aureus protein arginine kinase, McsB. [PDF]
Chetty R +4 more
europepmc +1 more source
RECQL4 requires PARP1 for recruitment to DNA damage, and PARG dePARylation facilitates its associated role in end joining. [PDF]
Hussain M +7 more
europepmc +1 more source
Synergistic Effect of Ubiquitin-Specific Protease 14 and Poly(ADP-Ribose) Glycohydrolase Co-Inhibition in BRCA1-Mutant, Poly(ADP-Ribose) Polymerase Inhibitor-Resistant Triple-Negative Breast Cancer Cells. [PDF]
Li P +7 more
europepmc +1 more source
O-GlcNAcylation of the tumor suppressor LATS1 drives mitotic progression via PLK1. [PDF]
Meng L, Wang Y, Zhou W, Wu S, Li J.
europepmc +1 more source
Protocol for synthesizing and purifying short-length poly(ADP)ribose polymer using fast protein liquid chromatography. [PDF]
Neeharika S, Hanuman DS, Rajakumara E.
europepmc +1 more source
A novel radiosensitizer α-sulfoquinovosyl-acylpropanediol (SQAP) inhibits DNA repair pathways and sensitize cells to cancer chemotherapeutic agents. [PDF]
Maeda J, Sunada S, Fukuhara T, Kato TA.
europepmc +1 more source
Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection. [PDF]
Zhang Z +17 more
europepmc +1 more source
Liquid‒liquid phase separation and poly(ADP‒ribosyl)ation in the context of ultraviolet radiation-induced stress in mammalian cells. [PDF]
Mejías D, Seballos V, Lafon-Hughes L.
europepmc +1 more source

